Immunmilieu

Immunmilieu, or immune microenvironment, denotes the locally organized network of immune and stromal elements that surround cells within a tissue. It integrates immune cells, resident stromal cells such as fibroblasts and endothelial cells, the extracellular matrix, and a dynamic milieu of cytokines, chemokines, growth factors, and metabolic byproducts. The immunmilieu is shaped by tissue context, infection, malignancy, and therapeutic intervention, and it can be proinflammatory and anti-pathogenic or immunosuppressive and tolerogenic. Key cellular components include T cells, B cells, natural killer cells, macrophages, dendritic cells, neutrophils, and eosinophils, as well as tissue-resident cells that modulate infiltration and activation. The spatial organization, activation state, and checkpoint receptor expression of these cells, along with soluble mediators, determine the strength and quality of immune responses.

In cancer, the immunmilieu—often referred to as the tumor immune microenvironment—influences prognosis and treatment response. Tumors with substantial effector T cell infiltration and proinflammatory signaling are sometimes termed 'hot' and more responsive to immunotherapies, whereas immunosuppressive milieus dominated by regulatory cells and inhibitory signals tend to correlate with resistance. Similar principles apply to infectious disease and autoimmune conditions, where shifting the immunmilieu toward effective clearance or tolerance can alter outcomes.

Study and manipulation of the immunmilieu employ immunohistochemistry, flow cytometry, transcriptomics, spatial profiling, and multiplex imaging, guiding strategies such as immune checkpoint inhibition, radiotherapy, and stromal targeting.